An international research team compared the Physician’s Global Assessment with separate evaluations of skin and musculoskeletal disease activity in PsA.
Reference1. Cauli A, Gladman DD, Mathieu A, et al; for the GRAPPA 3PPsA Study Group. Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study. J Rheumatol. 2018 Jun 15. pii: jrheum.171183. doi: 10.3899/jrheum.171183. [Epub ahead of print]
Cauli and fellow researchers at multiple international centers determined that the Physician’s Global Assessment (PGA) using the visual analog scale (VAS) is a good tool for assessing the totality of psoriatic arthritis activity, but they encourage assessment of both musculoskeletal and skin manifestations individually as well.1
Thumb through the slides for the details of the study and the take-home points for physicians.
(Image credit: ©Kentoh/Shutterstock.com)
ACR, American College of Rheumatology; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; PASI, Psoriasis Area and Severity Index; PGA, Physician’s Global Assessment; PsA, psoriatic arthritis.
MSK, musculoskeletal; PASI, Psoriasis Area and Severity Index; PGA, Physician’s Global Assessment; PhysMSK, Physician’s Musculoskeletal Assessment; PhysSk, Physician’s Skin Assessment; VAS, visual analog scale.